Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, you can take Mounjaro on your period. There is no clinical guidance or licensed restriction that says tirzepatide should be paused, delayed or avoided during menstruation. Your weekly injection schedule carries on as normal. That said, the relationship between Mounjaro and your cycle is worth understanding properly, because some people do notice changes — and knowing what is expected, what is coincidental, and what deserves a prescriber's attention makes a real difference. Mounjaro is a prescription-only medicine; a clinician assesses suitability before it is prescribed and remains your point of contact throughout treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks is whether a period date should shift the injection day. The short answer is no. Mounjaro's dosing schedule (one injection every seven days, same day each week) is not adjusted for menstruation. The NHS medicines page for tirzepatide does not list menstruation among the situations requiring a dose delay or pause. If your regular injection day happens to fall mid-period, you inject as planned.
What sometimes complicates this in practice is that nausea, fatigue and cramping are common both at the start of a new Mounjaro dose and during your period. The two can overlap unpleasantly. If you find the combination difficult, it is worth mentioning to your prescriber; they may have practical suggestions, though they are unlikely to recommend shifting your injection day for this reason alone. Keeping a simple log of your injection dates alongside your cycle can help both of you identify whether symptoms cluster in a meaningful pattern or are coincidental.
One practical note: Mounjaro is stored in the fridge and taken subcutaneously, so travel, holidays or disrupted routines around your period do not change storage requirements. The Patient Information Leaflet, available on the electronic Medicines Compendium, covers all storage and handling detail.
Mounjaro produces meaningful weight reduction for many people, and significant fat loss affects hormone levels. Adipose tissue is metabolically active; it produces and stores oestrogen. As body fat decreases, circulating oestrogen can shift, which in turn affects the hormonal signals that govern ovulation and the timing of periods. This is not a Mounjaro-specific phenomenon, it is a well-documented consequence of substantial weight change by any means.
The result can look like shorter cycles, longer gaps between periods, lighter flow, or, less commonly, heavier or more irregular bleeding. For people with polycystic ovary syndrome (PCOS), weight loss sometimes restores more regular ovulation, which may mean periods that were previously absent or infrequent begin to reappear. This has been reported anecdotally by many patients on GLP-1 medicines. You can read more about this on our page exploring whether Mounjaro can start a period that had stopped.
The broader question of how and why the menstrual cycle responds to treatment is covered in detail on our overview of how Mounjaro can affect your period. The NICE appraisal of tirzepatide, the active ingredient in Mounjaro (TA1026) does not specifically address menstrual effects, reflecting that the SURMOUNT trials were not designed to measure them; the evidence here is largely observational and emerging.
This is the area where taking Mounjaro during your cycle becomes genuinely consequential. Tirzepatide slows gastric emptying, which can reduce how efficiently the oral contraceptive pill is absorbed. NHS guidance is clear: during the first four weeks of Mounjaro treatment, and for four weeks after each dose increase, women taking the pill should use an additional non-oral method of contraception, condoms are the standard recommendation.
This matters most if you are sexually active and not planning a pregnancy. Mounjaro is not recommended during pregnancy, and if pregnancy is possible you should be using reliable contraception throughout treatment. The missed-absorption window is not permanent; once your body has adjusted to a given dose, the pill's effectiveness returns to normal. But the risk is real in those early weeks, and it is easy to miss in the focus on the injection itself.
If you use a patch, implant, injection or IUD rather than the pill, this particular concern does not apply in the same way, though discussing your contraception method with your prescriber at the start of treatment is good practice regardless. Our page on Mounjaro and late periods covers what to do if you are unsure whether a delayed period is cycle-related or something else.
Most changes to cycle timing or flow during Mounjaro treatment are benign and settle as weight loss stabilises. But some changes do need professional attention rather than watchful waiting. Seek advice from your GP or prescriber if: periods stop entirely for three or more consecutive months; bleeding becomes unusually heavy or prolonged; you experience pelvic pain that is new or significantly worse than your normal; or you have any reason to think pregnancy is possible.
At nume, every patient on treatment has access to clinical aftercare seven days a week. If something changes and you are uncertain, reaching out to us is the right first step rather than searching for reassurance online. You can also read about how Mounjaro can change your period and the factors that influence that, as well as general information about whether Mounjaro can stop periods. Mounjaro is a prescription-only medicine, for any clinical question specific to your circumstances, your prescriber is the right person to answer it.
If you are not yet on treatment and are thinking about whether Mounjaro is right for you, check your eligibility with a free consultation at our GPhC-registered pharmacy, where a named Independent Prescriber reviews every application the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.